Transdermal estrogen is a form of hormone therapy that delivers estradiol (the body’s primary estrogen) through the skin and directly into the bloodstream. It comes as patches, gels, or sprays, and is most commonly prescribed to treat hot flashes after menopause and to help prevent osteoporosis. The key difference from estrogen pills is that it bypasses the liver entirely, which changes its safety profile in meaningful ways.
How It Enters Your Body
Estradiol is a small molecule, which allows it to pass through the outermost layer of skin (the stratum corneum) relatively easily. Once through, it enters the tiny blood vessels in the deeper skin layers and flows into your general circulation. This is fundamentally different from swallowing an estrogen pill, which travels through your digestive system and gets processed by the liver before it ever reaches the rest of your body.
That liver processing, called first-pass metabolism, means oral estrogen requires higher doses to achieve the same effect. It also produces metabolites that can influence clotting factors and other proteins. Transdermal estrogen skips all of that, arriving in your bloodstream in a more natural, steady form and at lower doses.
Available Forms
There are three main delivery systems, and they differ mostly in how often you use them and where you apply them.
- Patches: Either once-weekly or twice-weekly (every 3 to 4 days), applied to the lower abdomen or upper buttock area. They release a steady, controlled dose around the clock.
- Gels: Applied once daily, typically to the upper arm. A standard dose is roughly 0.87 to 1.25 grams of gel per application, depending on the product.
- Sprays: Applied once daily, usually in the morning, to the inner forearm.
Patches are the most widely studied and commonly prescribed form. They come in a range of daily release rates: 0.025 mg, 0.0375 mg, 0.05 mg, 0.075 mg, and 0.1 mg per day. Most people start at the lowest dose, and their provider adjusts upward if symptoms aren’t adequately controlled.
What It’s Prescribed For
The FDA has approved transdermal estradiol for two primary uses: treating moderate to severe hot flashes caused by menopause, and preventing postmenopausal osteoporosis. For osteoporosis prevention specifically, guidelines note it should be considered mainly for women at significant risk when non-estrogen options aren’t suitable.
In practice, transdermal estrogen also helps with other menopause symptoms like night sweats, sleep disruption, and vaginal dryness (though very low-dose vaginal estrogen is often preferred for that last one). Some providers also prescribe it as part of hormone therapy for transgender women or for people with low estrogen from other causes, such as surgical removal of the ovaries.
Why It’s Considered Safer Than Pills
The biggest clinical advantage of transdermal estrogen is its effect on blood clot risk. Oral estrogen increases the risk of venous thromboembolism (blood clots in the legs or lungs), a concern that has shaped how many people think about hormone therapy in general. Transdermal estrogen does not appear to carry that same risk. Studies have consistently found no increase in clotting events among healthy postmenopausal women using patches, gels, or sprays.
This holds true even in higher-risk groups. Research on women with a prior history of blood clots found no increased risk of recurrence with transdermal estrogen, and some studies actually showed improved clotting profiles. Women with higher body weight, those with genetic predispositions to clotting, and those with inflammatory conditions all showed minimal to no increased clot risk when using the transdermal route.
The likely explanation is that oral estrogen’s trip through the liver triggers changes in proteins involved in blood clotting, while transdermal delivery avoids those metabolic changes altogether. For the same reason, transdermal estrogen appears to carry less risk of gallbladder disease than oral forms.
Who It’s Recommended For
The North American Menopause Society’s 2022 position statement specifically recommends the transdermal route for several groups. Women with moderate cardiovascular risk should consider it. Women with diabetes who are otherwise candidates for hormone therapy should lean toward a transdermal preparation. And for anyone using hormone therapy long-term, the guidance is to use the transdermal route at the lowest effective dose.
Even for women without specific risk factors, many providers now default to transdermal estrogen simply because it achieves the same symptom relief with a more favorable safety profile. The lower effective dose is another practical advantage: because you’re not losing a significant portion of the hormone to liver processing, less medication is needed overall.
Applying and Wearing Patches
Patches should go on clean, dry, cool skin below the waist, ideally on the lower abdomen or upper buttock. Avoid placing them on or near the breasts, over skin folds, or on any area that’s irritated or broken. Each time you apply a new patch, choose a different spot. Don’t reuse the same skin area back to back, as this can cause irritation. Waiting at least a week before returning to a previous site is a good rule.
A common concern is whether patches stay on during exercise, swimming, or hot weather. Research on patch adhesion during heat, humidity, and physical activity found that hormone delivery remained consistent under those conditions, and patch detachment was uncommon. A small number of patches came off during vigorous sports in one study, but this wasn’t a widespread problem. Most people can shower, swim, and exercise normally while wearing a patch.
For gels and sprays, the main consideration is letting the application site dry completely before covering it with clothing, and avoiding skin-to-skin contact with others at the application site for a period after applying, since the hormone can transfer.
Side Effects and Skin Reactions
The most common side effect specific to patches is skin irritation at the application site: redness, itching, or mild rash. Rotating sites with each application reduces this. Some people find certain patch brands more irritating than others, so switching products can help if irritation is persistent.
Beyond skin reactions, transdermal estrogen can cause the same general side effects as any estrogen therapy: breast tenderness, headaches, nausea (though less common than with pills), bloating, and spotting. These are typically dose-related and often improve within the first few months. Starting at a low dose and increasing gradually minimizes these effects.
For women who still have a uterus, estrogen therapy of any kind requires a progestogen alongside it to protect the uterine lining from overgrowth. This applies to transdermal estrogen just as it does to oral forms. Women who have had a hysterectomy can use estrogen alone.